Primary care physicians should take a patient-centred and stepped-care treatment approach in the delivery of care, depending on the patient's risk profile.[97]van der Feltz-Cornelis CM, Hoedeman R, Keuter EJ, et al. Presentation of the multidisciplinary guideline Medically Unexplained Physical Symptoms (MUPS) and Somatoform Disorder in the Netherlands: disease management according to risk profiles. J Psychosom Res. 2012 Feb;72(2):168-9.
http://www.ncbi.nlm.nih.gov/pubmed/22281461?tool=bestpractice.com
[98]Stewart M, Brown JB, Weston WW, et al. Patient-centered medicine: transforming the clinical method. Thousand Oaks, CA: Sage; 1995. Education and explanation of the diagnosis is the first step of management for both conditions. It is important to acknowledge the reality of the patient's symptoms and of their physical and emotional suffering. Take sufficient time, give the name of the condition, and provide further reading and support information.[99]Carson A, Lehn A, Ludwig L, et al. Explaining functional disorders in the neurology clinic: a photo story. Pract Neurol. 2016 Feb;16(1):56-61.
http://www.ncbi.nlm.nih.gov/pubmed/26769761?tool=bestpractice.com
An empathetic approach is key, but note that even when the diagnosis is presented with care, some people will respond with anger, humiliation, or distress. Follow-up explanations by other members of the multidisciplinary team in primary and secondary care may be useful.[71]Bennett K, Diamond C, Hoeritzauer I, et al. A practical review of functional neurological disorder (FND) for the general physician. Clin Med (Lond). 2021 Jan;21(1):28-36.
https://www.rcpjournals.org/content/clinmedicine/21/1/28
http://www.ncbi.nlm.nih.gov/pubmed/33479065?tool=bestpractice.com
Functional neurological disorder and somatic symptom disorder management often involves referral to consultative liaison psychiatrists or psychotherapists; referral to physical, occupational, or speech therapists as needed; and, when indicated, judicious use of somatic, depressive, or anxiety treatments. An integrative, multidisciplinary approach is necessary for all patients. Regular brief visits with primary care physicians (for somatic symptom disorder) and neurologists (for functional neurological disorder) should be scheduled to assess progress, maintain therapeutic relationships, avoid abandonment, and prevent excessive tests/procedures. After the initial diagnosis, psychiatric consultation followed by weekly phone contact may also improve quality of life.[100]Drane DL, LaRoche SM, Ganesh GA, et al. A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy Behav. 2016 Jan 1;54:34-9.
https://www.epilepsybehavior.com/article/S1525-5050(15)00586-7/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/26638037?tool=bestpractice.com
Although often ultimately the goal of treatment may be good management rather than cure, it may nonetheless be helpful to emphasise to patients from the offset that complete resolution of symptoms is possible.
Functional neurological disorder without comorbid anxiety and depression: stepped care management model
Step 1: Communication of the diagnosis and patient education
The diagnosis should be made and explained by a neurologist, a neuropsychiatrist, and/or another clinician with expertise in neurological examination.[3]Perez DL, Aybek S, Popkirov S, et al; American Neuropsychiatric Association Committee for Research. A review and expert opinion on the neuropsychiatric assessment of motor functional neurological disorders. J Neuropsychiatry Clin Neurosci. 2021 Winter;33(1):14-26.
https://neuro.psychiatryonline.org/doi/10.1176/appi.neuropsych.19120357
http://www.ncbi.nlm.nih.gov/pubmed/32778007?tool=bestpractice.com
They should demonstrate positive clinical signs to illustrate the underlying mechanisms involved.[101]Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology. 2012 Jul 17;79(3):282-4.
http://www.ncbi.nlm.nih.gov/pubmed/22764261?tool=bestpractice.com
The aim is to provide validation of the patient's symptoms, and to offer a confident diagnosis that negates the need to seek an alternative medical opinion.
Useful phrases to adapt may include:[71]Bennett K, Diamond C, Hoeritzauer I, et al. A practical review of functional neurological disorder (FND) for the general physician. Clin Med (Lond). 2021 Jan;21(1):28-36.
https://www.rcpjournals.org/content/clinmedicine/21/1/28
http://www.ncbi.nlm.nih.gov/pubmed/33479065?tool=bestpractice.com
"Functional neurological disorder is a problem with the functioning of the nervous system. It's a problem with the software rather than the hardware."
If this explanation is not fully understood, an alternative may be: "It's like a piano that's out of tune; not broken, just not working properly."
A useful way to describe prognosis could be: "This is not an easy problem to put right, but it does have the potential to improve, and many people do make a good recovery."
Regarding the need for psychological or psychiatric input: "It's common in functional neurological disorder for people to have problems like anxiety and depression. For some, there are things that have happened which may explain why your brain is vulnerable to going wrong in this way and could be worth exploring. I think a psychiatric/psychological assessment could be helpful. What do you think?"
It is important to develop a sense of partnership between patient and clinician, and an understanding of the likely next steps in management (including psychological treatment).[74]Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018 Sep 1;75(9):1132-41.
http://www.ncbi.nlm.nih.gov/pubmed/29868890?tool=bestpractice.com
Internet resources to signpost to include:
Step 2: Brief rehabilitation plus psychological therapy
If problematic symptoms persist following explanation of the diagnosis, the next step is usually to offer a brief rehabilitation intervention directed towards specific symptoms, in combination with psychological therapy (e.g., cognitive behavioural therapy).
For example, those with motor or gait disturbance may benefit from physiotherapy, whereas speech and language therapy is recommended for those with speech and swallowing disturbance.[92]Baker J, Barnett C, Cavalli L, et al. Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy. J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1112-25.
https://jnnp.bmj.com/content/92/10/1112
http://www.ncbi.nlm.nih.gov/pubmed/34210802?tool=bestpractice.com
[102]Nielsen G, Buszewicz M, Stevenson F, et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):484-90.
https://jnnp.bmj.com/content/88/6/484
http://www.ncbi.nlm.nih.gov/pubmed/27694498?tool=bestpractice.com
Occupational therapy may be more generally applicable for improving function and engagement with everyday activities.[103]Nicholson C, Edwards MJ, Carson AJ, et al. Occupational therapy consensus recommendations for functional neurological disorder. J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1037-45.
https://jnnp.bmj.com/content/91/10/1037
http://www.ncbi.nlm.nih.gov/pubmed/32732388?tool=bestpractice.com
For patients with functional seizures, general principles of management include helping the patient to recognise triggers and warning symptoms in order to avert episodes, and to learn and challenge safety or avoidance behaviours around episodes.[74]Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018 Sep 1;75(9):1132-41.
http://www.ncbi.nlm.nih.gov/pubmed/29868890?tool=bestpractice.com
The evidence base for rehabilitation treatments for functional neurological disorder is growing, and there is now good evidence (predominantly from randomised controlled trials) in particular for physiotherapy for motor symptoms.[102]Nielsen G, Buszewicz M, Stevenson F, et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):484-90.
https://jnnp.bmj.com/content/88/6/484
http://www.ncbi.nlm.nih.gov/pubmed/27694498?tool=bestpractice.com
[104]Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1113-9.
https://jnnp.bmj.com/content/86/10/1113
http://www.ncbi.nlm.nih.gov/pubmed/25433033?tool=bestpractice.com
[105]Czarnecki K, Thompson JM, Seime R, et al. Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. Parkinsonism Relat Disord. 2012 Mar;18(3):247-51.
http://www.ncbi.nlm.nih.gov/pubmed/22113131?tool=bestpractice.com
[106]Jordbru AA, Smedstad LM, Klungsøyr O, et al. Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med. 2014 Feb;46(2):181-7.
https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-1246
http://www.ncbi.nlm.nih.gov/pubmed/24248149?tool=bestpractice.com
[107]Nielsen G, Ricciardi L, Demartini B, et al. Outcomes of a 5-day physiotherapy programme for functional (psychogenic) motor disorders. J Neurol. 2015 Mar;262(3):674-81.
http://www.ncbi.nlm.nih.gov/pubmed/25557282?tool=bestpractice.com
Successful programmes incorporate physiotherapy delivered by a therapist with experience of functional neurological disorder, delivered within a psychologically informed framework (e.g., incorporating psychoeducation and stress reduction techniques). The aim is to focus on function and automatic movement rather than on individual components of the movement and symptoms (e.g., weakness). Counter-productive thinking styles and behaviours should be addressed during physiotherapy, such as avoidance of particular movements in an attempt to avoid damage.[74]Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018 Sep 1;75(9):1132-41.
http://www.ncbi.nlm.nih.gov/pubmed/29868890?tool=bestpractice.com
[104]Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1113-9.
https://jnnp.bmj.com/content/86/10/1113
http://www.ncbi.nlm.nih.gov/pubmed/25433033?tool=bestpractice.com
Psychological therapy (e.g., cognitive behavioural therapy [CBT]) is a key aspect of treatment for most patients, ideally delivered by a therapist with experience in managing functional neurological disorder.[108]Sharpe M, Walker J, Williams C, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology. 2011 Aug 9;77(6):564-72.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149156
http://www.ncbi.nlm.nih.gov/pubmed/21795652?tool=bestpractice.com
According to one Cochrane review there is insufficient evidence overall to recommend any particular psychological intervention for functional neurological disorder.[109]Ganslev CA, Storebø OJ, Callesen HE, et al. Psychosocial interventions for conversion and dissociative disorders in adults. Cochrane Database Syst Rev. 2020 Jul 17;(7):CD005331.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005331.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/32681745?tool=bestpractice.com
However, several other individual studies and systematic reviews suggest benefit with CBT, CBT-based guided self-help, CBT-group training, mindfulness therapy, short-term dynamic psychotherapy, re-attribution training, and augmented psychodynamic interpersonal psychotherapy.[108]Sharpe M, Walker J, Williams C, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology. 2011 Aug 9;77(6):564-72.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149156
http://www.ncbi.nlm.nih.gov/pubmed/21795652?tool=bestpractice.com
[110]Gutkin M, McLean L, Brown R, et al. Systematic review of psychotherapy for adults with functional neurological disorder. J Neurol Neurosurg Psychiatry. 2021 Jan;92(1):36.
https://jnnp.bmj.com/content/92/1/36
http://www.ncbi.nlm.nih.gov/pubmed/33154184?tool=bestpractice.com
[111]Goldstein LH, Robinson EJ, Mellers JDC, et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry. 2020 Jun;7(6):491-505.
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30128-0/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/32445688?tool=bestpractice.com
[112]van Dessel N, den Boeft M, van der Wouden JC, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014 Nov 1;(11):CD011142.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011142.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/25362239?tool=bestpractice.com
[113]LaFrance WC Jr, Baird GL, Barry JJ, et al; NES Treatment Trial (NEST-T) Consortium. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry. 2014 Sep;71(9):997-1005.
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1884286
http://www.ncbi.nlm.nih.gov/pubmed/24989152?tool=bestpractice.com
[114]Hedman E, Axelsson E, Görling A, et al. Internet-delivered exposure-based cognitive-behavioural therapy and behavioural stress management for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2014 Oct;205(4):307-14.
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/internetdelivered-exposurebased-cognitivebehavioural-therapy-and-behavioural-stress-management-for-severe-health-anxiety-randomised-controlled-trial/89639C4D604B8C352DDA5F2B751AD5D2
http://www.ncbi.nlm.nih.gov/pubmed/25104835?tool=bestpractice.com
[115]Zonneveld LN, van Rood YR, Timman R, et al. Effective group training for patients with unexplained physical symptoms: a randomized controlled trial with a non-randomized one-year follow-up. PLoS One. 2012 Aug 7;7(8):e42629. [Erratum in: PLoS One. 2013 May 13;8(5).]
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0042629
http://www.ncbi.nlm.nih.gov/pubmed/22880056?tool=bestpractice.com
[116]Fjorback LO. Mindfulness and bodily distress. Dan Med J. 2012 Nov;59(11):B4547.
https://www2.ugeskriftet.dk/files/scientific_article_files/2018-11/b4547.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23171754?tool=bestpractice.com
[117]Fjorback LO, Arendt M, Ornbøl E, et al. Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up. J Psychosom Res. 2013 Jan;74(1):31-40.
http://www.ncbi.nlm.nih.gov/pubmed/23272986?tool=bestpractice.com
[118]Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders: systematic review and meta-analysis of clinical trials. Psychother Psychosom. 2009;78(5):265-74.
http://www.ncbi.nlm.nih.gov/pubmed/19602915?tool=bestpractice.com
[119]Erceg-Hurn DM. Psychodynamic therapy for somatic disorder meta-analysis raises more questions than answers. Psychother Psychosom. 2011 Mar 9;80(3):182-3.
http://www.ncbi.nlm.nih.gov/pubmed/21389755?tool=bestpractice.com
[120]Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;(7):CD004687.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004687.pub4/full
http://www.ncbi.nlm.nih.gov/pubmed/24984083?tool=bestpractice.com
[
]
What are the effects of psychological therapies for adults with somatic symptom disorder or medically unexplained physical symptoms (MUPS)?/cca.html?targetUrl=https://www.cochranelibrary.com/cca/doi/10.1002/cca.2344/fullShow me the answer
[
]
Is there randomized controlled trial evidence to support the use of short-term psychodynamic psychotherapies in people with common mental disorders?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.464/fullShow me the answer In practice, eclectic psychotherapeutic approaches are often used, but evidence is limited and more randomised controlled trials of longer duration (>12 months) are needed.[121]Kleinstauber M, Witthöft M, Hiller W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev. 2011 Feb;31(1):146-60.
http://www.ncbi.nlm.nih.gov/pubmed/20920834?tool=bestpractice.com
[122]Martlew J, Pulman J, Marson AG. Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database Syst Rev. 2014 Feb 11;(2):CD006370.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006370.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/24519702?tool=bestpractice.com
[123]Kisely SR, Campbell LA, Yelland MJ, et al. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev. 2015 Jun 30;(6):CD004101.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004101.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/26123045?tool=bestpractice.com
Eclectic psychotherapy includes a combination of CBT, mindfulness, interpersonal psychotherapy, short-term dynamic psychotherapy, and general psychotherapy.
Patients with functional neurological disorder may benefit from learning self-hypnosis as one tool to control symptoms, and so hypnosis may be considered as an adjunctive treatment.[124]Moene FC, Spinhoven P, Hoogduin KA, et al. A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychother Psychosom. 2002 Mar-Apr;71(2):66-76.
http://www.ncbi.nlm.nih.gov/pubmed/11844942?tool=bestpractice.com
[125]Moene FC, Spinhoven P, Hoogduin KA, et al. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn. 2003 Jan;51(1):29-50.
http://www.ncbi.nlm.nih.gov/pubmed/12825917?tool=bestpractice.com
Eclectic psychotherapy involves:
Insight into psychological mechanisms and patterns (e.g., between the physical and emotional; and between current or past relationships and symptoms)
Understanding and recognising problematic interpersonal relationships
Developing ways to express and process emotions effectively
Developing a new relationship with symptoms that involves acceptance, non-judgemental awareness of symptoms and symptom dynamics, and self-compassion, rather than trying to control the somatic symptoms
Creating strategies to recognise and resolve conflicts
Using cognitive and behavioural strategies such as changing maladaptive thinking, relaxation strategies, and managing symptoms (the type of CBT varies for each group).
Step 3: Further psychological therapy
Patients who do not respond to initial therapies (brief rehabilitation intervention in combination with psychological therapy [e.g., CBT]) may benefit from further psychological therapy.
Further psychological therapy involves:
Administering psychodynamic psychotherapy
Administering family therapy - recognising unspeakable dilemmas (the suppression of a conflict arising from family, social, or political events due to the belief that it must remain concealed from key persons involved), and interrupting spousal reinforcement of illness behaviours[126]Schade N, Torres P, Beyebach M. Cost-efficiency of a brief family intervention for somatoform patients in primary care. Fam Syst Health. 2011 Sep;29(3):197-205.
http://www.ncbi.nlm.nih.gov/pubmed/21767015?tool=bestpractice.com
[127]Griffith JL, Polles A, Griffith ME. Pseudoseizures, families, and unspeakable dilemmas. Psychosomatics. 1998 Mar-Apr;39(2):144-53.
http://www.ncbi.nlm.nih.gov/pubmed/9584540?tool=bestpractice.com
Administering group therapy
Administering dialectical behavioural therapy - using in vivo coaching, homework assignments, and skills groups to help patients cope with rapidly shifting emotions and problematic reactions to emotional stimuli (particularly with comorbid borderline personality disorder or trauma)[128]Wagner AW, Rizvi SL, Harned MS. Applications of dialectical behavior therapy to the treatment of complex trauma-related problems: when one case formulation does not fit all. J Trauma Stress. 2007 Aug;20(4):391-400.
http://www.ncbi.nlm.nih.gov/pubmed/17721961?tool=bestpractice.com
Administering paradoxical intention therapy (encourages the patient to deliberately engage in the unwanted behaviour)
Administering eye-movement desensitisation-reprocessing (particularly with comorbid post-traumatic stress disorder).
Biofeedback training may be considered as an adjunct to further psychotherapy.[74]Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018 Sep 1;75(9):1132-41.
http://www.ncbi.nlm.nih.gov/pubmed/29868890?tool=bestpractice.com
This helps patients influence automatic, involuntary bodily functions (e.g., brain waves, blood pressure, heart rate, muscle tension, skin temperature, sweat gland activity) and better understand the mind-body connection by measuring bodily functions, using information about how bodily functions contribute to bodily tension and stress, and incorporating relaxation training; it is unlikely to cure patients of functional neurological disorder if other treatment modalities are not used conjunctively.
Step 4: Specialised multidisciplinary therapy
Patients with problematic symptoms in spite of steps 1-3 (e.g., those with complex symptom presentations and/or high levels of disability) may benefit from specialised multidisciplinary therapy conducted in an outpatient or inpatient setting. This approach has shown positive results in single-centre studies.[129]Jacob AE, Kaelin DL, Roach AR, et al. Motor retraining (MoRe) for functional movement disorders: outcomes from a 1-week multidisciplinary rehabilitation program. PM R. 2018 Nov;10(11):1164-72.
http://www.ncbi.nlm.nih.gov/pubmed/29783067?tool=bestpractice.com
[130]McCormack R, Moriarty J, Mellers JD, et al. Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):895-900.
http://www.ncbi.nlm.nih.gov/pubmed/24124043?tool=bestpractice.com
[131]Saifee TA, Kassavetis P, Pareés I, et al. Inpatient treatment of functional motor symptoms: a long-term follow-up study. J Neurol. 2012 Sep;259(9):1958-63.
http://www.ncbi.nlm.nih.gov/pubmed/22584953?tool=bestpractice.com
[132]Demartini B, Batla A, Petrochilos P, et al. Multidisciplinary treatment for functional neurological symptoms: a prospective study. J Neurol. 2014 Dec;261(12):2370-7.
https://link.springer.com/article/10.1007/s00415-014-7495-4
http://www.ncbi.nlm.nih.gov/pubmed/25239392?tool=bestpractice.com
[133]Aybek S, Lidstone SC, Nielsen G, et al. What Is the role of a specialist assessment clinic for FND? Lessons from three national referral centers. J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):79-84.
https://neuro.psychiatryonline.org/doi/10.1176/appi.neuropsych.19040083
http://www.ncbi.nlm.nih.gov/pubmed/31587627?tool=bestpractice.com
Functional neurological disorder with comorbid anxiety and depression: stepped care model
Steps 1-4: Usual management plus adjunctive pharmacotherapy
Management follows the same stepped care model as above, but with the addition of adjunctive pharmacological treatment directed towards symptoms of depression and anxiety.[74]Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018 Sep 1;75(9):1132-41.
http://www.ncbi.nlm.nih.gov/pubmed/29868890?tool=bestpractice.com
Specialist input is typically required (e.g., from a medical psychologist or consultant liaison psychiatrist).
Pharmacological treatment options for comorbid depression or anxiety include selective serotonin-reuptake inhibitors (SSRIs), particularly for anxiety disorders; serotonin-noradrenaline reuptake (serotonin-norepinephrine reuptake) inhibitors (SNRIs), particularly for co-existent pain syndromes; tricyclic antidepressants; mirtazapine; or bupropion.
Patients who do not benefit from eclectic psychotherapy (including CBT) and antidepressant therapy may be treated with further psychological therapies.
Steps 5 and 6: Additional options
If the above management is not effective, atypical antipsychotics may be tried. If augmentation strategies are not effective, electroconvulsive therapy (ECT) or repetitive transcranial magnetic stimulation (rTMS) may be considered. Evidence supporting the use of atypical antipsychotics, ECT, or rTMS for functional neurological disorder is limited.[134]Prigatano GP, Stonnington CM, Fisher RS. Psychological factors in the genesis and management of nonepileptic seizures: clinical observations. Epilepsy Behav. 2002 Aug;3(4):343-9.
http://www.ncbi.nlm.nih.gov/pubmed/12609332?tool=bestpractice.com
[135]Drake ME Jr, Pakalnis A, Phillips BB. Neuropsychological and psychiatric correlates of intractable pseudoseizures. Seizure. 1992 Mar;1(1):11-3.
http://www.ncbi.nlm.nih.gov/pubmed/1364248?tool=bestpractice.com
[136]Marazziti D, Dell'Osso B. Effectiveness of risperidone in psychogenic stiff neck. CNS Spectr. 2005 Jun;10(6):443-4.
http://www.ncbi.nlm.nih.gov/pubmed/15908897?tool=bestpractice.com
[137]Persinger MA. Seizure suggestibility may not be an exclusive differential indicator between psychogenic and partial complex seizures: the presence of a third factor. Seizure. 1994 Sep;3(3):215-9.
http://www.ncbi.nlm.nih.gov/pubmed/8000716?tool=bestpractice.com
[138]Dabholkar PD. Use of ECT in hysterical catatonia: a case report and discussion. Br J Psychiatry. 1988 Aug;153:246-7.
http://www.ncbi.nlm.nih.gov/pubmed/3255441?tool=bestpractice.com
[139]Daniel WF, Crovitz HF. ECT-induced alteration of psychogenic amnesia. Acta Psychiatr Scand. 1986 Sep;74(3):302-3.
http://www.ncbi.nlm.nih.gov/pubmed/3788657?tool=bestpractice.com
[140]Edwards JG. Electroconvulsive therapy in the treatment of bizarre psychogenic movements. Br J Psychiatry. 1969 Sep;115(526):1065-7.
http://www.ncbi.nlm.nih.gov/pubmed/4989776?tool=bestpractice.com
[141]Chastan N, Parain D, Verin E, et al. Psychogenic aphonia: spectacular recovery after motor cortex transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):94.
http://www.ncbi.nlm.nih.gov/pubmed/19091717?tool=bestpractice.com
[142]Geraldes R, Coelho M, Rosa MM, et al. Abnormal transcranial magnetic stimulation in a patient with presumed psychogenic paralysis. J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1412-3.
http://www.ncbi.nlm.nih.gov/pubmed/19010957?tool=bestpractice.com
[143]Schonfeldt-Lecuona C, Connemann BJ, Spitzer M, et al. Transcranial magnetic stimulation in the reversal of motor conversion disorder. Psychother Psychosom. 2003 Sep-Oct;72(5):286-8.
http://www.ncbi.nlm.nih.gov/pubmed/12920333?tool=bestpractice.com
[144]Oriuwa C, Mollica A, Feinstein A, et al. Neuromodulation for the treatment of functional neurological disorder and somatic symptom disorder: a systematic review. J Neurol Neurosurg Psychiatry. 2022 Mar;93(3):280-90.
http://www.ncbi.nlm.nih.gov/pubmed/35115389?tool=bestpractice.com
However, when mood or anxiety disorders are present these treatments may have added value for treating the comorbid condition.
Somatic symptom disorder without comorbid anxiety or depressive disorder: stepped care management model
Step 1: Communication of the diagnosis and patient education
Patient education including careful delivery of the diagnosis is the first step of management. Before delivering a diagnosis of somatic symptom disorder, carefully explore what the patient thinks is wrong, and tailor the explanation accordingly.[145]Page LA, Wessely S. Medically unexplained symptoms: exacerbating factors in the doctor-patient encounter. J R Soc Med. 2003 May;96(5):223-7.
https://journals.sagepub.com/doi/10.1177/014107680309600505
http://www.ncbi.nlm.nih.gov/pubmed/12724431?tool=bestpractice.com
One approach to giving the diagnosis is to explain that there is no evidence of a serious or life-threatening illness, and to emphasise that this is positive news. The explanation may include: "You have a condition that is common but not yet fully understood, which we know to cause the group of symptoms you are experiencing."
Initial management usually takes place within primary care, with regular follow-up visits scheduled (e.g., every 4-8 weeks) that are not dependent on symptoms.[146]Gordon-Elliott JS, Muskin PR. An approach to the patient with multiple physical symptoms or chronic disease. Med Clin North Am. 2010 Nov;94(6):1207-16, xi.
http://www.ncbi.nlm.nih.gov/pubmed/20951278?tool=bestpractice.com
Evidence on treatment is limited, but a practical approach to initial primary care management based on expert opinion and several review articles includes:[97]van der Feltz-Cornelis CM, Hoedeman R, Keuter EJ, et al. Presentation of the multidisciplinary guideline Medically Unexplained Physical Symptoms (MUPS) and Somatoform Disorder in the Netherlands: disease management according to risk profiles. J Psychosom Res. 2012 Feb;72(2):168-9.
http://www.ncbi.nlm.nih.gov/pubmed/22281461?tool=bestpractice.com
[145]Page LA, Wessely S. Medically unexplained symptoms: exacerbating factors in the doctor-patient encounter. J R Soc Med. 2003 May;96(5):223-7.
https://journals.sagepub.com/doi/10.1177/014107680309600505
http://www.ncbi.nlm.nih.gov/pubmed/12724431?tool=bestpractice.com
[146]Gordon-Elliott JS, Muskin PR. An approach to the patient with multiple physical symptoms or chronic disease. Med Clin North Am. 2010 Nov;94(6):1207-16, xi.
http://www.ncbi.nlm.nih.gov/pubmed/20951278?tool=bestpractice.com
[147]Croicu C, Chwastiak L, Katon W. Approach to the patient with multiple somatic symptoms. Med Clin North Am. 2014 Sep;98(5):1079-95.
http://www.ncbi.nlm.nih.gov/pubmed/25134874?tool=bestpractice.com
Exploration of symptoms, including patient's thoughts and emotions in response to these, including impact on functioning
Conducting brief physical examinations focusing on areas of discomfort at each visit
Establishing a therapeutic alliance, acknowledging that the patient's symptoms are real
Limiting tests and referrals unless symptoms change
Communication with specialists treating the patient
Gradual discontinuation of unnecessary medications
Psychoeducation (e.g., explaining that the body may generate symptoms in the absence of disease)
Mutually agreed realistic and incremental goals for improvement of functioning.
If no medical cause of symptoms has been identified, note that it is not possible to completely exclude the presence of an underlying medical condition via negative investigation results, although the probability of falsely reassuring results is low. By acknowledging this uncertainty to patients, clinicians can avoid offering facile reassurance, which may exacerbate fears. Advise patients to report any changing, worsening, or new symptoms, as they may warrant re-assessment.[148]den Boeft M, Claassen-van Dessel N, van der Wouden JC. How should we manage adults with persistent unexplained physical symptoms? BMJ. 2017 Feb 8;356:j268.
http://www.ncbi.nlm.nih.gov/pubmed/28179237?tool=bestpractice.com
Step 2: Psychological therapy
Psychological therapy may be beneficial as the next step. Discussion with a psychiatrist may also be helpful to cover a review of initial management, to ensure this has been appropriate, and verification of the diagnosis. It is important to explain this sensitively, as patients may consider the involvement of psychiatric clinicians as evidence that their symptoms are believed to be 'all in their head'.
In practice, psychological therapy may include eclectic psychotherapy (including CBT, mindfulness, and/or short-term dynamic psychotherapy).[112]van Dessel N, den Boeft M, van der Wouden JC, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014 Nov 1;(11):CD011142.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011142.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/25362239?tool=bestpractice.com
[118]Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders: systematic review and meta-analysis of clinical trials. Psychother Psychosom. 2009;78(5):265-74.
http://www.ncbi.nlm.nih.gov/pubmed/19602915?tool=bestpractice.com
[149]Smith GR Jr, Monson RA, Ray DC. Psychiatric consultation in somatization disorder: a randomized controlled study. N Engl J Med. 1986 May 29;314(22):1407-13.
http://www.ncbi.nlm.nih.gov/pubmed/3084975?tool=bestpractice.com
[150]Hoedeman R, Blankenstein AH, van der Feltz-Cornelis CM, et al. Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006524.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006524.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/21154369?tool=bestpractice.com
CBT in this group involves:
Reducing physiological arousal through relaxation techniques
Enhancing activity regulation through increased exercise, and pleasurable and meaningful activities
Pacing activities
Increasing awareness of emotions
Modifying dysfunctional beliefs
Enhancing communication of thoughts and emotions
Reducing spousal reinforcement of illness behaviour.
Patients being treated with eclectic psychotherapy (including CBT) may also benefit from the following adjunctive treatments:
Graded physical exercise (GET): patients are gently introduced to exercise by only gradually increasing the amount of daily exertions; the aim is to begin with very short periods of exercise, such as walking or swimming, just to the point of toleration, and then each week to attempt to increase the amount of exercise with the goal of increasing tolerance and capacity for exercise.[151]Henningsen P. Management of somatic symptom disorder. Dialogues Clin Neurosci. 2018 Mar;20(1):23-31.
http://www.ncbi.nlm.nih.gov/pubmed/29946208?tool=bestpractice.com
[152]Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007 Mar 17;369(9565):946-55.
http://www.ncbi.nlm.nih.gov/pubmed/17368156?tool=bestpractice.com
The rationale for offering graded exercise is based on its use in other conditions with overlapping symptoms, such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); note that there have been serious concerns expressed regarding the potential for iatrogenic harm with GET in ME/CFS, and its use is no longer recommended in ME/CFS by the National Institute for Health and Care Excellence (NICE) in the UK for this reason.[153]National Institute for Health and Care Excellence. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. Oct 2021 [internet publication].
https://www.nice.org.uk/guidance/ng206
It is important to acknowledge that this is a topic of polarised discussion; the current evidence base concerning the possibility of iatrogenic harm with GET is hindered by methodological shortcomings, and there a lack of widespread consensus among experts regarding the balance between its risks and benefits.
Biofeedback training: the goal is to better understand the mind-body connection and to learn ways to use relaxation training; any patient may potentially benefit, especially those with genitourinary and/or gastrointestinal (GI) complaints who will learn to relax those organ systems. The rationale for considering biofeedback is based on its use in pain syndromes and other mind-body disorders.
Step 3: Referral to a psychiatrist
For patients whose symptoms have not responded adequately to steps 1-2, psychiatric referral is the next recommended step, with continued regular input in primary care. In order to avoid engendering feelings of abandonment, it can be helpful to emphasise that you will continue to help the patient, but that you are seeking input from a colleague to better help you do this. There is evidence that even a single visit with a psychiatrist may improve outcomes.[150]Hoedeman R, Blankenstein AH, van der Feltz-Cornelis CM, et al. Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006524.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006524.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/21154369?tool=bestpractice.com
Evidence on pharmacological treatment is limited, low-quality, and often indirect.[154]Kleinstäuber M, Witthöft M, Steffanowski A, et al. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev. 2014 Nov 7;(11):CD010628.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010628.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/25379990?tool=bestpractice.com
[155]Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med. 2007 Dec;69(9):889-900.
http://www.ncbi.nlm.nih.gov/pubmed/18040100?tool=bestpractice.com
[156]Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007 Dec;69(9):881-8.
http://www.ncbi.nlm.nih.gov/pubmed/18040099?tool=bestpractice.com
[157]O'Malley PG, Jackson JL, Santoro J, et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract. 1999 Dec;48(12):980-90.
http://www.ncbi.nlm.nih.gov/pubmed/10628579?tool=bestpractice.com
A specialist may consider offering antidepressant therapy (with tricyclic antidepressants, SNRIs, SSRIs, mirtazapine, or bupropion), particularly in cases of pain syndromes or cyclic vomiting.[155]Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med. 2007 Dec;69(9):889-900.
http://www.ncbi.nlm.nih.gov/pubmed/18040100?tool=bestpractice.com
Even if pain or cyclic vomiting are not the primary target symptoms, there is low-quality evidence for pharmacological therapies being effective compared with placebo in treating medically unexplained symptoms, with no one class of antidepressant or natural supplement being superior to another; benefits thus need to be weighed against their adverse effects.[154]Kleinstäuber M, Witthöft M, Steffanowski A, et al. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev. 2014 Nov 7;(11):CD010628.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010628.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/25379990?tool=bestpractice.com
Step 4: Further psychotherapy
Patients who do not respond to initial therapies (eclectic psychotherapy and/or pharmacotherapy) may benefit from further psychotherapy, including psychodynamic psychotherapy; family therapy (recognising unspeakable dilemmas and interrupting spousal reinforcement of illness behaviours); group therapy; dialectical behavioural therapy (particularly with comorbid borderline personality disorder or trauma); paradoxical intention therapy (encourages the patient to deliberately engage in the unwanted behaviour); and eye-movement desensitisation-reprocessing (particularly with comorbid post-traumatic stress disorder).[127]Griffith JL, Polles A, Griffith ME. Pseudoseizures, families, and unspeakable dilemmas. Psychosomatics. 1998 Mar-Apr;39(2):144-53.
http://www.ncbi.nlm.nih.gov/pubmed/9584540?tool=bestpractice.com
[128]Wagner AW, Rizvi SL, Harned MS. Applications of dialectical behavior therapy to the treatment of complex trauma-related problems: when one case formulation does not fit all. J Trauma Stress. 2007 Aug;20(4):391-400.
http://www.ncbi.nlm.nih.gov/pubmed/17721961?tool=bestpractice.com
Somatic symptom disorder with comorbid depressive or anxiety disorder: stepped care model
Steps 1-4: Usual management plus adjunctive pharmacotherapy
Management follows the same stepped care model as above, but with the addition of adjunctive pharmacological treatment directed towards symptoms of depression and anxiety. Specialist input is typically required (e.g., from a consultant psychiatrist).[148]den Boeft M, Claassen-van Dessel N, van der Wouden JC. How should we manage adults with persistent unexplained physical symptoms? BMJ. 2017 Feb 8;356:j268.
http://www.ncbi.nlm.nih.gov/pubmed/28179237?tool=bestpractice.com
Pharmacological treatment options for comorbid depression or anxiety include SSRIs (particularly for anxiety disorders); SNRIs (particularly with predominant pain); tricyclic antidepressants; mirtazapine; or bupropion.
Step 5: Atypical antipsychotic
Atypical antipsychotic medication can be offered by a specialist to patients who do not respond to further psychotherapy. When mood or anxiety disorders are present it may have added value for treating the comorbid condition. Consult a specialist for guidance on dose and choice of medication.